Kangmei Pharmaceutical Co., Ltd. (SHA: 600518)
1.760
-0.010 (-0.57%)
Sep 6, 2024, 3:00 PM CST
Kangmei Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 244.14 | 102.52 | -2,688 | 7,918 | -31,085 | -4,661 | Upgrade
|
Depreciation & Amortization | 334.93 | 340.48 | 365.69 | 603.22 | 644.83 | 695.14 | Upgrade
|
Other Amortization | 29.94 | 28.19 | 27.73 | 35.19 | 133.15 | 109.55 | Upgrade
|
Loss (Gain) From Sale of Assets | -27.6 | -19.61 | -0.98 | -64.01 | 44.96 | 19.03 | Upgrade
|
Asset Writedown & Restructuring Costs | 99.25 | 99.97 | 307.46 | 2,643 | 1,508 | 587.82 | Upgrade
|
Loss (Gain) From Sale of Investments | -64.33 | -44.4 | -0.75 | -188.79 | 4.59 | -767.71 | Upgrade
|
Provision & Write-off of Bad Debts | -257.17 | -238.47 | 213.41 | 1,192 | 1,003 | 34.95 | Upgrade
|
Other Operating Activities | 176.49 | 196.51 | 278.14 | 2,577 | 26,027 | 2,972 | Upgrade
|
Change in Accounts Receivable | 171.21 | 215.15 | -339.53 | -746.88 | 3,130 | 956.6 | Upgrade
|
Change in Inventory | -374.75 | -93.01 | -253.62 | 1,666 | 1,912 | 1,752 | Upgrade
|
Change in Accounts Payable | -765.84 | -896.42 | 1,321 | -15,587 | -2,298 | 1,177 | Upgrade
|
Change in Other Net Operating Assets | - | - | - | 0.59 | -8.93 | -122.48 | Upgrade
|
Operating Cash Flow | -446.2 | -317.52 | -749.96 | 214.21 | 1,031 | 2,882 | Upgrade
|
Operating Cash Flow Growth | - | - | - | -79.23% | -64.21% | 843.03% | Upgrade
|
Capital Expenditures | -87.46 | -99.74 | -48.12 | -171.63 | -301.73 | -473.2 | Upgrade
|
Sale of Property, Plant & Equipment | 56.82 | 52.25 | 1.55 | 77.9 | 1,135 | 3.6 | Upgrade
|
Divestitures | 17.5 | 9.85 | - | 57.72 | -0.74 | 29.25 | Upgrade
|
Investment in Securities | - | - | - | -0.53 | - | 313.05 | Upgrade
|
Other Investing Activities | - | - | 0.55 | 0.04 | - | -41.46 | Upgrade
|
Investing Cash Flow | -13.14 | -37.64 | -46.02 | -36.51 | 832.06 | -168.76 | Upgrade
|
Short-Term Debt Issued | - | - | - | 127.64 | - | - | Upgrade
|
Long-Term Debt Issued | - | - | - | - | 10,572 | 11,176 | Upgrade
|
Total Debt Issued | - | - | - | 127.64 | 10,572 | 11,176 | Upgrade
|
Short-Term Debt Repaid | - | - | - | -97.03 | - | - | Upgrade
|
Long-Term Debt Repaid | - | -72.71 | -94.95 | -48.66 | -11,419 | -12,701 | Upgrade
|
Total Debt Repaid | -58.08 | -72.71 | -94.95 | -145.69 | -11,419 | -12,701 | Upgrade
|
Net Debt Issued (Repaid) | -58.08 | -72.71 | -94.95 | -18.05 | -847.07 | -1,525 | Upgrade
|
Issuance of Common Stock | 0.5 | - | - | 1,800 | - | - | Upgrade
|
Common Dividends Paid | - | - | -0.9 | -13.82 | -1,032 | -2,547 | Upgrade
|
Dividends Paid | - | - | -0.9 | -13.82 | -1,032 | -2,547 | Upgrade
|
Other Financing Activities | -35 | -48.14 | -21.01 | 0.25 | 2.77 | 26.89 | Upgrade
|
Financing Cash Flow | -92.58 | -120.85 | -116.86 | 1,768 | -1,876 | -4,045 | Upgrade
|
Foreign Exchange Rate Adjustments | -0 | 0 | 0 | -0.04 | -0.25 | 0.35 | Upgrade
|
Net Cash Flow | -551.93 | -476.01 | -912.84 | 1,946 | -13.13 | -1,331 | Upgrade
|
Free Cash Flow | -533.66 | -417.27 | -798.08 | 42.58 | 729.67 | 2,409 | Upgrade
|
Free Cash Flow Growth | - | - | - | -94.16% | -69.71% | - | Upgrade
|
Free Cash Flow Margin | -10.73% | -8.56% | -19.09% | 1.03% | 13.48% | 21.05% | Upgrade
|
Free Cash Flow Per Share | -0.05 | -0.04 | -0.06 | 0.00 | 0.05 | 0.49 | Upgrade
|
Cash Interest Paid | 0.91 | 0.91 | 1.06 | - | - | 3.28 | Upgrade
|
Cash Income Tax Paid | 301.56 | 211.36 | 284.45 | 235.31 | 295.57 | 304.44 | Upgrade
|
Levered Free Cash Flow | -399.31 | -278.02 | 117.24 | -6,029 | 21,968 | 4,071 | Upgrade
|
Unlevered Free Cash Flow | -364.32 | -242.92 | 166.55 | -5,391 | 23,320 | 5,476 | Upgrade
|
Change in Net Working Capital | 835.78 | 640.19 | -471.46 | 3,953 | -39,589 | -6,308 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.